Vital Energy, Inc. (VTLE) Earnings Call Transcript
August 25, 2025
Earnings Call Speaker Segments
Greetings. Welcome to Crescent Energy's acquisition of Vital Energy Conference Call. [Operator Instructions]. Please note that this conference is being recorded. At this time, I'll hand the conference over to Reid Gallagher with Investor Relations. Reid, you may now begin.
Good morning, and thank you for joining this call covering Crescent's announced transaction with Vital Energy. Our prepared remarks today will come from our CEO, David Rockecharlie, along with Vital's President and CEO, Jason Pigott. We'll also have our CFO, Brandi Kendall, and other members of our leadership team available during Q&A. Today's call may contain projections and other forward-looking statements within the meaning of federal securities laws. These statements are subject to risks and uncertainties, including commodity price volatility, global geopolitical conflict, our business strategies and other factors that may cause actual results to differ materially from those expressed or implied in these statements and our other disclosures. We have no obligation to update any forward-looking statements after today's call. With that, I will turn it over to our CEO, David.
Good morning, everyone, and thank you for joining us today. We're pleased to announce that Crescent Energy has signed a definitive agreement to acquire Vital Energy in an all-stock transaction, creating a top 10 independent operator with line of sight to an investment-grade rating. Alongside this acquisition, we are increasing our noncore divestiture pipeline to $1 billion. With these steps, we are even better positioned. Crescent will have more focus, more scale and more potential to deliver long-term value to shareholders. Before getting into the merits of the transaction, I want to commend Jason and everyone on the team at Vital for the business that they have built. Crescent is looking forward to integrating Vital's attractive Permian assets into our portfolio and becoming a part of the Midland community. We are proud to welcome the Vital team into the Crescent organization. Turning to the transaction. I would like to start by highlighting the 3 things I hope you all take away from this call. First, this acquisition represents compelling value, generating attractive cash-on-cash investment returns in line with our target of greater than 2x multiple of invested capital, with the valuation covered by Vital's existing production base and delivering immediate and significant accretion to both near-term and long-term metrics, including more than 20% accretion to 5-year free cash flow per share and more than 10% accretion to net asset value per share. Second, as always, we will apply Crescent's consistent strategy to this acquisition. We plan to high-grade capital allocation on Vital's assets by reducing activity and increasing both free cash flow and returns. This is a leverage-accretive business plan. Our approach to pro forma operations, combined with our $1 billion divestiture pipeline, supports our commitment to an investment-grade balance sheet and to our attractive peer-leading return of capital program. And finally, with this scaled entry into the Permian, we significantly expand Crescent's opportunity for future growth, with more than $60 billion of asset acquisition potential surrounding our pro forma footprint. In the Eagle Ford, we have demonstrated our playbook for our accretive growth through acquisition strategy, and we are confident in our ability to continue to execute across our combined portfolio. I will now go over the key terms of the transaction, which is structured as an all-stock deal. Each Vital shareholder will receive 1.9062 shares of Crescent common stock for each share of Vital common stock. Upon closing, which is expected by year-end, Vital shareholders will own approximately 23% of the combined company on a fully diluted basis. Both Boards have unanimously approved the transaction and major shareholders of both companies are party to agreements serving to support the transaction. Following close, the Crescent Board will expand to 12 members and 10 representatives from Crescent and 2 from Vital. As mentioned in my opening remarks, this attractive combination creates a top 10 independent, catalyzing a step change in Crescent's market positioning with attractive tailwinds from an increased investor pool, incremental index inclusion and a potential ratings uplift with enhanced scale. The combined company will have an enterprise value of approximately $9 billion and a free cash flow generation capacity comparable to our new top 10 peers. The transaction provides a substantial foothold in the Permian that complements our existing scaled positions across the Eagle Ford and the Uinta. Together, the combined company produces nearly 400,000 barrels of oil equivalent per day with nearly $13 billion of total proved SEC reserves and has capital allocation flexibility across basins and commodities that support significant and sustainable free cash flow generation through commodity cycles. The combined company will hold nearly 1 million net acres across its core areas with more than a decade of low-risk development inventory and significant resource upside to support our development program far into the future. We operate some of the largest positions across both the Eagle Ford and Uinta Basins, and this transaction provides a scaled foothold in the Permian, where we see significant opportunity for future growth. Vital contributes substantial and competitive inventory to our pro forma portfolio that generates attractive returns in today's price environment. We also expect to deliver meaningful pro forma efficiencies, including $90 million to $100 million of immediate annual savings to further enhance our free cash flow focused operating plan. These savings are straightforward, driven by Crescent's more favorable cost of debt, lower corporate overhead as we eliminate redundant public company expenses and meaningful interest savings as our operating plan improves returns and free cash flow and accelerates debt repayment. Altogether, the 5-year PV-10 of our expected synergies is approximately $350 million, which covers about 11% of the headline transaction value. Beyond these immediate savings, we see significant potential for operational efficiency gains across the acquired assets as well as longer-term cost of capital benefits as we advance towards our goal of being an investment-grade business. These opportunities, while not included in our valuation, represent potential for more than $100 million in incremental annual savings or more than $200 million combined with our base case synergies. But we want to give ourselves time to do this right. We've demonstrated our ability to find the goals buried in assets we acquire through efficient execution and improved operating performance, and we are confident in our ability to maximize the value of this transaction for investors. Under our operating plan and including our baseline synergy expectations, we expect 5-year cumulative free cash flow well in excess of our combined market cap. We've always had a free cash flow-focused business model, and our strategy applied to these assets creates compelling value for all shareholders. With our increased base of free cash flow, our capital allocation priorities remain consistent with a continued focus on putting our investors first. As we always say, priorities 1A and 1B with free cash flow are maintaining a strong balance sheet and returning capital to our shareholders. Through this transaction, we will maintain our fixed $0.12 per share quarterly dividend, which offers an extremely compelling yield versus our peers as well as our existing $150 million buyback authorization. This transaction enhances our investment-grade quality balance sheet with an improved credit profile driven by increased scale and our leverage accretive business plan, and it makes Crescent the largest liquids-weighted producer yet to receive an investment-grade rating. We have no financing requirements associated with the transaction. And at closing, we expect to maintain our current leverage of 1.5x, within the bounds of our target leverage range of 1 to 1.5x. We also have $1.5 billion of liquidity. On top of our substantial cash flow generation, we see significant opportunity to drive value and accelerate further deleveraging through incremental asset divestitures. We announced a $250 million divestiture pipeline in the fourth quarter of last year, and we now see $1 billion of divestiture opportunity in the pro forma company. With our strong balance sheet, substantial free cash flow and a highly executable divestiture pipeline, we continue to advance towards our ambition of being an investment-grade business. We have a proven track record of returns-driven growth through M&A, averaging 3 acquisitions per year over the last decade. We hold ourselves accountable to a consistent underwriting criteria, and we've demonstrated our ability to acquire and integrate successfully. With our consistent strategy, we've more than tripled production and grown annual cash flow more than fivefold since our public listing about 4 years ago, all while maintaining the strength of our balance sheet and increasing our credit ratings. Our recent success in the Eagle Ford highlights our value proposition of thoughtful investing, efficient integration and operational improvement to build a basin-leading position. We saw a highly fragmented basin with a compelling growth opportunity, and we got to work, executing on a transformative series of transactions, completing 7 acquisitions over 2 years to more than triple our asset footprint, production base and inventory. We integrated each asset seamlessly, and we relentlessly pursued operational efficiencies, driving approximately $200 million in annual synergies across these recent acquisitions. We consistently execute our playbook for M&A success, and this transaction offers a unique opportunity to use it in a basin with the largest acquisition opportunity set remaining in the Lower 48. The addition of a scaled Permian position significantly expands Crescent's scope for accretive growth. We now have more than $60 billion of potential growth opportunities surrounding our pro forma footprint in the Eagle Ford and Permian, and we are confident in our ability to capitalize on it. With that, I'd like to welcome Jason to share a few thoughts before we close.
Thanks, David. This is an exciting new chapter for Vital Energy and a compelling value proposition for our shareholders, providing attractive value and accelerating our trajectory in a larger and better positioned combined business. This transaction is fully aligned with the strategies we've consistently pursued, creating long-term value through responsible growth and capital discipline. Our investors will be part of a combined company that is extremely well positioned in our sector with a scaled asset portfolio across premier basins, a strong balance sheet, significant free cash flow generation, supporting peer-leading dividend and a large opportunity set for future growth. In addition to the financial and strategic metrics, our companies share similar values and a commitment to safe and responsible operations. With those shared principles and complementary strengths, I am confident this combination will create meaningful and lasting value for all stakeholders. I also want to express my sincere gratitude to the employees of Vital. Your dedication, hard work and commitment to -- commitment have built a company we can all be proud of, one with high-quality assets, operational excellence and integrity and discipline. Without you, we wouldn't be in a position to make a transformative step for our business. With that, I'll turn the call back over to David.
Great. Thank you, Jason. Before we close, I want to reiterate the 3 things I hope everyone takes away from this call. First, this combination represents compelling value for our shareholders with attractive acquisition returns and significant accretion across all key financial metrics. Second, we plan to align these assets under our consistent strategy with lower activity, higher returns and higher free cash flow, plus a $1 billion divestiture pipeline to maximize value for investors and accelerate our path to investment grade. And finally, we have more than $60 billion of potential opportunities surrounding the pro forma [ footprint ] and we are confident in our ability to continue to grow the business accretively from here. This acquisition and our $1 billion noncore divestiture pipeline are transformative for our business, but there is no change to our strategy. With these steps, we are even better positioned. Crescent will have more focus, more scale and more potential to deliver long-term value to shareholders, to enable for step change, and we'll be working hard to deliver. With that, I'll open it up to Q&A.
[Operator Instructions]. And the first question this morning comes from the line of Neal Dingmann with William Blair.
David, congrats and Jason, congrats on your side. Obviously, Jason love working with you all. David, my first question is just the assets. Obviously, I know the Vital assets quite well. I'm just curious how you and the team believe that the vital assets will immediately start to compete for capital. Is it fair to say that a good bit of it will go in the upper quartile of your inventory? Or how do you see this?
Yes, great question. I would say that we're really pleased to fold it into our business plan, and I think we look at it as adding incremental oil inventory to the business. So yes, very strongly competes. But as you heard us say, we are going to significantly reduce activity on those assets, and we think that's going to allow us to high-grade the development within the context of our broader plan and our core assets.
So David, in that same vein then, could you talk about when you look at sort of pro forma rig count for the company, I mean would it be one in one and have you decided yet one in one in Midland and Delaware in these assets? Or I'm just trying to think of how you sort of think about the pro forma D&C going forward?
Yes. I think too early to sort of start providing any, what I'll call, forward guidance. But generally, just so you have some context, Vital has been running about 4 rigs, and we see a program that's more likely in the 1 to 2 range.
Okay. And then if I could sneak one last one in just on the divestitures, the noncore. I mean, is that something you're planning -- do you have a time line on that? And is there any assets you could talk about that you've already identified there?
Yes. As you have heard from us before, we started this process of what I'll call, streamlining the company in the fourth quarter. And what you're hearing from us is that you can assume we're getting after it, and we're confident in the pipeline and our ability to capture value sooner rather than later.
The next question is from the line of Tim Rezvan with KeyBanc Capital Markets.
We found the Permian entry to be interesting, especially in light of the hire of your COO in May, who has significant experience there. But can you talk about the change? What made you decide that being an Eagle Ford Shale consolidator was not going to be the path forward and that you're going to kind of expand your opportunity set? What led you to that decision?
Yes. Great question. I think the first thing to know, we look at everything in the market. So we're constantly trying to pay attention to that, in particular, areas that we think fit our operating skill set and assets we can fold into our plan. So in general, we don't think this is a change in terms of operating profile or strategy. We're getting great value with the business. And as for the Eagle Ford, no change there. We see a huge opportunity, and we'll be even better positioned as a company following this acquisition. And I think what you're hearing from us with both this transaction and the divestiture program is, as I said in the earlier remarks, I think we're getting more scale, but also more opportunity around both the Permian and Eagle Ford going forward.
Okay. Okay. That makes sense. I appreciate that. And then, David, in the past, you've talked about being comfortable in that 1 to 1.5x leverage because of the low PDP decline of the business. I believe it went from 19% to 25% with SilverBow. So how does that change? You haven't said what you're going to sell, but it's likely that the Barnett Shale or conventional Rockies, some of these more mature assets would leave. So how do you think about pro forma leverage if you're running a higher PDP decline business?
Yes. A couple of things. Just to hit the decline upfront, we're still committed to what I would call our core targets of a 50% or lower reinvestment rate and a 25% decline rate. And while you're correct that our conventional assets have had traditionally lower decline, it's a really small part of the business. And you'll see that through the cycle, we've acquired shale assets that were sub-20%. And then a lot of times, we acquire assets that were operated in a different business plan that come into the company at a higher decline rate and then we manage that into our position. So that's in terms of strategy or asset profile and portfolio, maybe worth hitting upfront. But then turning to the leverage question specifically, our stand-alone business is 1.5x levered today and on a great path. We expect to fully repay the RBL by year-end. Vital is above our 1.5x target, but we expect to close at 1.5x given the free cash flow generation from both businesses. And obviously, the $1 billion pipeline of divestitures, we feel confident about that adding to the balance sheet as well. And then the other thing I would highlight to your question, we've got confidence in the balance sheet management. It comes from over a decade of running the business with average leverage of 1.2x. And as we've talked about together before, it may take a bit longer at lower prices or a bit faster at higher prices, but we're committed to the strategy, and we'll get there.
Our next question is from the line of Charles Meade with Johnson Rice.
Picking up on that point of debt management, I understand the details are going to need to wait for post close. But can you give us an idea of what you would regard as kind of positive milepost or positive achievements post close in '26 on the debt front, what that would look like?
Yes. I think in general, the business generates significant free cash flow. And hopefully, what you're hearing very strongly from us is that combined, we're going to have a significant increase in free cash flow driven partly by lower activity and higher returns. Going forward, we just expect to continue to delever out of free cash flow. The business is well positioned. And I'll just -- maybe one just great example of what we hope you'll continue to hear from us is in the second quarter, we paid down a couple of hundred million of debt and used 80% plus or minus of the free cash flow has been targeted to debt repayment. So we feel very good about it.
Got it. Got it. And then to the point about reducing activity on the Vital assets, can you elaborate a bit more on that? Is this just kind of harmonizing the reinvestment on those assets with your existing philosophy of just -- so going from 4 to 1 to 2 rigs? Or is this is this also -- you're going to keep the best kind of the projects. So is there an element of this that some of those projects for rigs 3 and 4, say, for example, aren't going to -- wouldn't compete in the combined company portfolio?
Yes. As a starting point, we would say we find this asset position really attractive. And so we're -- just to confirm for you, we're going to bring it into our business strategy and operate it how Crescent operates. That is different than others in the industry. And first of all, I'd say that Vital strategy had included more growth through the [ Dilbert ] approach along with the acquisitions they were doing, and that just hasn't been our style from the beginning. So we're going to maximize cash flow and returns here. But the other thing I think worth highlighting is we also like to take our time. And so we think there's great capital projects to do here. But as we look at this business, we want to do this right. And so taking your time and being able to high-grade inventory plan within the context of our broader portfolio and then also integrate and high-grade among the opportunities we have to develop is just the way we like to do things. So I'm confident that we're going to be successful. We have high conviction around the quality of the inventory available to us here, but we're just going to take it slower, and we think that's going to be better for all the shareholders.
Our next question is from the line of Michael Scialla with Stephens.
Congratulations. David, you mentioned some upside on the operations. Just want to see if you could provide any more color on things you might attack there to increase that synergy target number.
Yes. Great question. And obviously, we've got a lot of confidence in the first $100 million. And so we're really focused on that second $100 million. We didn't include these in the base underwriting. But what I would say, we've been able to get these same things in prior acquisitions. And so same potential exists here, again, back to some of the comments about inventory high grading as well. We're going to give ourselves the time to get it right. But I think it's across everything, LOE, D&C efficiencies. We've brought different completion practices to every acquisition. And so I think it's the normal playbook, but just going to take us some time to get things integrated and optimized. So we're excited about the opportunity, but we need to go get after that.
And I'm assuming you've -- as you mentioned, you look at everything, you've, I'm sure, looked at other Permian opportunities. You've even owned some Permian assets in the past. I guess I wanted to ask what made Vital the right one to transact on at this point? I mean not every day you can obviously do an all-stock transaction that's accretive, but anything beyond valuation that you can point to really tell us why this deal made sense at this time.
Yes. It's both from the entry point for us and the significant upside, just a really attractive compelling investment opportunity, and we think the combined company is great for all the shareholders. So everything with us starts with investment returns and no difference here. To your point, we do look at everything, but we also think about what's the ability for us to drive operational performance and future growth. So we want to be scaled. The team at Vital put together an attractive position that really lends itself to our operating strategy. So we're excited about what we can do, just bringing it in, again, to how we like to operate from a free cash flow perspective. And then it's just a huge area and opportunity for further consolidation just like we pursued in the Eagle Ford. So we think the resource in this basin is tremendous. We've looked at it for a long time. And I think we're very good at being disciplined and patient, and this was a great chance for us to get in with what I'll call a set of assets that fit us really well for our operating philosophy.
Our next question the line of John Abbott with Wolfe Research.
I guess at this point in time, you're not really providing pro forma guidance, but Vital really didn't have any sort of time line to pay cash taxes. I guess the question for you, Brandi, is how -- what is the potential benefit to Crescent on the tax side from this transaction?
So I would say at a high level, no anticipated changes to the guidance we provided on our Q2 earnings with respect to cash taxes as a pro forma business. We don't anticipate being a material cash taxpayer over the next couple of years with the caveats being that, that's highly dependent on commodity prices and ultimate capital programs. I would say no change to what we would have talked about a couple of weeks ago.
And then my follow-up question will be on the $1 billion in noncore divestitures. You have the $250 million target you've been able to execute on things. There is commodity volatility out there. There's some concern prices for oil could be lower towards the end of the year. I mean, how do you think about commodity divestitures and commodity volatility? And when you look at your assets, I mean, does the mineral -- some sort of sale of your mineral business sort of makes sense at this point in time?
Yes, great question. So first thing, our 3 core areas where we see the most growth potential pro forma are the Eagle Ford, the Permian and Uinta. Everything else, we constantly evaluate for opportunities to maximize value. I think the most clear way I can answer your question on volatility and timing is, as I said earlier, we announced a divestiture program in the fourth quarter of last year. We have been very active in the market. And I would say, feel very good and confident about the pipeline increase that we've announced today. And again, I think our focus and ability to capture value sooner rather than later is something we're trying to convey.
Thank you. At this time, we've reached the end of our question-and-answer session. I'll hand the call to David Rockecharlie for closing remarks.
Great. Thanks, everybody. Again, we want to welcome the entire Vital team, and I appreciate Jason sitting here with me today as we were able to share this great news with both of our shareholders. And we look forward to getting the transaction closed appropriately and getting after the combined business together and making sure that investors get a great outcome across the board. So we look forward to keeping you up to date, and thank you for joining us.
This will conclude today's conference. You may disconnect your lines at this time. We thank you for your participation, and have a wonderful day.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Vital Energy, Inc. transcript - plus 251,000+ transcripts from 12,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Vital Energy, Inc. earnings transcripts and 251,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $105 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.